(Press-News.org) La Jolla, Calif., July 23, 2015 - A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer. The results, published today in the online edition of Gut, could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide.
"Our findings point to a new way to improve the treatment of liver cancer patients," said Carl Ware, Ph.D., professor and director in the Infectious and Inflammatory Disease Center at SBP and one of theauthors of the paper. "Combining drugs that are currently in clinical trials, which block the activity of the LTβR with drugs that target oncogene signals, may be a valuable new approach to improving patient outcomes."
The LTβR, originally discovered by Ware, is best known for controlling the development of lymphoid organs, supporting the body's immune response to pathogens, and regulating inflammation. His work has led to the understanding that blocking the activity of the receptor inhibits inflammation. This approach is currently studied as a treatment for chronic inflammatory diseases, including Sjögren's syndrome.
"For some time we have known about the interconnection between the receptor, inflammation--including inflammation caused by hepatitis--and liver cancer. Now, we have demonstrated how the receptor's signals create an environment that accelerates oncogenic activity and tumor growth," added Ware.
Working with Robert Wiltrout, Ph.D., and Anthony Scarzello in the Cancer and Inflammation Program at the National Cancer Institute, the research team introduced the liver cancer-causing AKT/β-catenin or AKT/Notch oncogenes to mice and then monitored liver cancer progression after administration of either a LTβR activator (agonist) or an inhibitor (antagonist). In mice that received the agonist, liver tumors rapidly proliferated and progressed. In contrast, mice that received the antagonist experienced reduced tumor progression and enhanced survival.
Importantly, the research team found that LTβR levels were elevated in human liver cancer cell lines, reflecting the need for enhanced receptor activity to maintain oncogene activity. Similarly, higher levels of the receptor correlated with poor survival in patients with intrahepatic cholangiocarcinoma, the second most common type of liver tumor.
"Cancers of the hepatobiliary system, including cholangiocarcinoma and hepatocellular carcinoma, typically present in advanced stages, with impaired liver function, respond poorly to chemotherapy, and have poor survival based on the lack of available treatment options," said Paul Timothy Fanta, M.D., associate clinical professor in the Division of Hematology and Oncology at UC San Diego's Moores Cancer Center."
"The present study describes interactions of the LTβR, a member of the tumor necrosis factor (TNF) superfamily of receptors and may play a key role in tumor formation through LTβR inflammation-mediated events and actions through AKT/Beta-catenin and Notch cellular pathways. The link between LTβR signaling and oncogenic activation suggests that drugs targeting LTβR signaling combined with AKT or Notch inhibitors may lead to rationally designed therapeutic trials in these underserved and lethal diseases," added Fanta.
INFORMATION:
The study was performed in collaboration with the Cancer and Inflammation Program and the Laboratory of Human Carcinogenesis at the Center for Cancer Research, National Cancer Institute (USA), and the Chulaborhan Research Institute (Thailand).
This study was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH), and NIH grants R01CA164679, P01CA177322, and R37AI33068.
About Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent nonprofit research organization that blends cutting-edge fundamental research with robust drug discovery to address unmet clinical needs in the areas of cancer, neuroscience, immunity, and metabolic disorders. The Institute invests in talent, technology, and partnerships to accelerate the translation of laboratory discoveries that will have the greatest impact on patients. Recognized for its world-class NCI-designated Cancer Center and the Conrad Prebys Center for Chemical Genomics, SBP employs more than 1,100 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at SBPdiscovery.org. The Institute can also be found on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
In the first study to document updated treatment trends, researchers found that from 2010 to 2013, 40 percent of men with low-risk prostate cancer opted for active surveillance, in which the disease is monitored closely with blood tests, imaging studies and biopsies. Treatment is deferred unless these tests show evidence ...
Today an international team of astronomers from NASA's Kepler mission have announced the discovery of a near-Earth-sized planet in the habitable zone of a Sun-like star.
Dr Daniel Huber from the University of Sydney's School of Physics is part of the team which made the discovery with NASA's Kepler Space Telescope.
The planet named Kepler-452b is 60 per cent larger than Earth and orbits a Sun-like star with an orbital period of 385 days.
The mere 20 day difference between the planet's orbital period and that of Earth's makes it the closest analogue to Earth ever ...
EU's grid connected cumulative capacity in 2014 reached 129 GW, meeting 8% of European electricity demand, equivalent to the combined annual consumption of Belgium, the Netherlands, Greece and Ireland. According to a JRC report, the impressive growth of the industry will allow at least 12% electricity share by 2020, a significant contribution to the goal of the European energy and climate package of 20% share of energy from renewable sources.
The 2014 JRC wind status report presents the technology, market and economics of the wind energy sector with a focus on the EU. ...
Scientists at the University of York believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy.
It is hoped that this new development could pave the way for more effective treatments - allowing a lower dose of radiotherapy to be used while prolonging the lives of thousands of men.
Prostate cancer is the most commonly diagnosed form of male cancer in the UK and kills more than 11,000 men every year.
In the latest studies, published in European Urology and the British Journal of Cancer, scientists in The ...
July 24, 2015 - Patient satisfaction ratings after surgery for spinal degenerative disease--especially in terms of reduced pain and disability--are a good indicator of the procedure's effectiveness, reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Wolters Kluwer.
"Patient satisfaction with outcome may accurately represent the effectiveness of surgical spine care in terms of one-year improvement in pain and disability," according to the new research by Dr. Clinton J. Devin of Vanderbilt ...
It doesn't happen often that a young scientist makes a significant and unexpected discovery, but postdoctoral researcher Stephen Wu of the U.S. Department of Energy's Argonne National Laboratory just did exactly that. What he found--that you don't need a magnetic material to create spin current from insulators--has important implications for the field of spintronics and the development of high-speed, low-power electronics that use electron spin rather than charge to carry information.
Wu's work upends prevailing ideas of how to generate a current of spins. "This is a ...
Needham, MA.-JBJS Case Connector, an online case report journal published by The Journal of Bone and Joint Surgery, has issued a "Watch" regarding potential risks with anchor-based all-inside meniscal repairs. While all-inside techniques have many advantages, including shorter surgical time and reduced risk of damage to neurovascular tissues, potential drawbacks include risks of local soft-tissue irritation and implant migration or breakage.
In particular, the "Watch" offers important tips for successfully using FAST-FIX meniscal-repair devices produced by Smith & Nephew. ...
Nailing the diagnosis of a psychiatric disorder may not be important in prescribing effective treatment, according to Mark Zimmerman, M.D., a clinical researcher at Rhode Island Hospital. His opinion editorial was published online today in the Journal of Clinical Psychiatry.
"During the past 35 years, we have witnessed a revolution in the treatment of psychiatric disorders," said Zimmerman, director of outpatient psychiatry and the partial hospital program at Rhode Island Hospital and director of the Rhode Island Methods to Improve Diagnostic Assessment and Services ...
A new Animal Conservation study shows that sports stadium lighting can alter patterns of bat species activity and feeding, which may in turn have cascading effects on other organisms and the ecosystem as a whole.
Using a novel field experiment, Dr. M. Corrie Schoeman demonstrates that urban exploiter bats are more likely to hunt insects attracted to bright light pollution sources such as stadiums than urban avoider bats. (Exploiter organisms can take advantage of food or resources supplied by humans, while avoider organisms have either a history of conflict with humans ...
In a recent year-long study, 40% of patients with chronic obstructive pulmonary disease (COPD) experienced falls, with more than 75% of these falling multiple times.
Factors linked with an increased risk of falling included smoking, having other illnesses, taking multiple medications, having a fear of falling, and falling in the past.
"The findings could be useful for developing preventative strategies," said Dr. Cristino Oliveira, lead author of the Respirology study.
INFORMATION:
...
